iSpecimen (NASDAQ:ISPC) Announces Quarterly Earnings Results

iSpecimen (NASDAQ:ISPC) announced its quarterly earnings results on Monday. The company reported ($0.71) earnings per share for the quarter, Zacks reports. iSpecimen had a negative return on equity of 139.25% and a negative net margin of 91.66%.

iSpecimen Stock Performance

ISPC stock traded up $0.04 during mid-day trading on Monday, reaching $1.17. 14,646 shares of the stock traded hands, compared to its average volume of 414,723. iSpecimen has a one year low of $1.02 and a one year high of $11.80. The stock has a market capitalization of $2.92 million, a PE ratio of -0.06 and a beta of 1.73. The business has a 50-day moving average price of $1.24 and a two-hundred day moving average price of $2.34.

iSpecimen Company Profile

iSpecimen Inc provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers.